Prevention of hepatitis E: another step forward

被引:5
作者
Goel, Amit [1 ]
Aggarwal, Rakesh [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India
关键词
hepatitis E; randomized controlled trial; vaccine; E VIRUS HEV; E VACCINE; INFECTION; IMMUNOGENICITY; CHALLENGE; EFFICACY; TRIAL;
D O I
10.2217/FMB.10.151
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Zhu F-C, Zhang J, Zhang X-F et al.: Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, Phase 3 trial. Lancet 376, 895-902 (2010). Hepatitis E virus (HEV) is frequently implicated in cases with acute viral hepatitis, particularly in developing countries. The infection, transmitted mainly by the fecal-oral route, is generally self-limited. A few affected individuals develop fulminant hepatic failure, a serious condition that is frequently fatal without liver transplantation. This outcome is particularly common when the infection occurs in pregnant women. A vaccine that contains a recombinant truncated capsid protein of HEV produced in an insect cell system has already been shown to be effective in preventing hepatitis E, at least in young men. However, it is not yet available on the market. In the evaluated article, Zhu et al. report the results of a large field trial of another vaccine against hepatitis E that contains a shorter part of the viral capsid protein, produced in Escherichia coli and adsorbed on alum. This trial, which included a large number of subjects of either gender aged 18-65 years, found this newer vaccine as safe and highly effective in preventing clinical disease caused by infection with HEV belonging to the genotype from which the vaccine was derived as well as another genotype. This study should prove to be a major stepping stone in our fight against this important disease pathogen.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 21 条
[1]   Hepatitis E vaccine [J].
Aggarwal, Rakesh ;
Jameel, Shahid .
HEPATOLOGY INTERNATIONAL, 2008, 2 (03) :308-315
[2]   Epidemiology of hepatitis E: Current status [J].
Aggarwal, Rakesh ;
Naik, Sita .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (09) :1484-1493
[3]   Autochthonous hepatitis E in southwest England [J].
Dalton, H. R. ;
Thurairajah, P. H. ;
Fellows, H. J. ;
Hussaini, H. S. ;
Mitchell, J. ;
Bendall, R. ;
Banks, M. ;
Ijaz, S. ;
Teo, C. -G. ;
Levine, D. F. .
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (05) :304-309
[4]   Persistent Carriage of Hepatitis E Virus in Patients with HIV Infection. [J].
Dalton, Harry R. ;
Bendall, Richard P. ;
Keane, Frances E. ;
Tedder, Richard S. ;
Ijaz, Samreen .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) :1025-1027
[5]   Hepatitis E virus and chronic hepatitis in organ-transplant recipients. [J].
Kamar, Nassim ;
Selves, Janick ;
Mansuy, Jean-Michel ;
Ouezzani, Leila ;
Peron, Jean-Marie ;
Guitard, Joelle ;
Cointault, Olivier ;
Esposito, Laure ;
Abravanel, Florence ;
Danjoux, Marie ;
Durand, Dominique ;
Vinel, Jean-Pierre ;
Izopet, Jacques ;
Rostaing, Lionel .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (08) :811-817
[6]   INCIDENCE AND SEVERITY OF VIRAL-HEPATITIS IN PREGNANCY [J].
KHUROO, MS ;
TELI, MR ;
SKIDMORE, S ;
SOFI, MA ;
KHUROO, MI .
AMERICAN JOURNAL OF MEDICINE, 1981, 70 (02) :252-255
[7]  
Kumar Arvind, 2004, Indian J Gastroenterol, V23, P59
[8]   A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates [J].
Li, SW ;
Zhang, J ;
Li, YA ;
Ou, SH ;
Huang, GY ;
Huang, GY ;
He, ZQ ;
Ge, SX ;
Xian, YL ;
Pang, SQ ;
Ng, MH ;
Xia, NS .
VACCINE, 2005, 23 (22) :2893-2901
[9]   Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis [J].
Lu, L ;
Li, CH ;
Hagedorn, CH .
REVIEWS IN MEDICAL VIROLOGY, 2006, 16 (01) :5-36
[10]   Acute hepatitis E in south-west France over a 5-year period [J].
Mansuy, J. M. ;
Abravanel, F. ;
Miedouge, M. ;
Mengelle, C. ;
Merviel, C. ;
Dubois, M. ;
Kamar, N. ;
Rostaing, L. ;
Alric, L. ;
Moreau, J. ;
Peron, J. M. ;
Izopet, J. .
JOURNAL OF CLINICAL VIROLOGY, 2009, 44 (01) :74-77